INTRODUCTION

Excelsior is established in the early 1980s. In the initial stages, Excelsior operated as an agent for blood dialysis equipment and consumables, gradually transitioning into an integrated service provider in healthcare channel . Enfield Medical Co., Ltd. succeeded in IPO in 2002 and become a public listing company, renamed as Excelsior Medical Co., Ltd. in 2009, except for deeply cultivating the field of dialysis medical equipment, professional maintenance, and channel operations, it was actively expanding into ophthalmologic and dental clinics with a chain system, long-term care centers, health appliances, pharmaceutical warehousing and logistics service and procurement supply, medical management information, and venturing into the medical aesthetics market.
After developed and accumulated know-how from industry practices and experiences for many years, with core competency, Excelsior Group continues to expand its investment and operation in the biotechnology and medical industries. At the same time, it has actively established a presence in Mainland China and advanced the internationalization of the group, achieving a strategic position that spans from Taiwan to the international stage.